Biology-driven approaches to prevent and treat relapse of myeloid neoplasia after allogeneic hematopoietic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Biology of Blood and Marrow Transplantation, 25, 4, S. e128-e140
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2019
- Event
-
Veröffentlichung
- (where)
-
Amsterdam [u.a.]
- (who)
-
Elsevier
- (when)
-
2019
- Creator
-
Zeiser, Robert
Beelen, Dietrich W.
Bethge, Wolfgang Andreas
Bornhäuser, Martin
Bug, Gesine
Burchert, Andreas
Christopeit, Maximilian Erich Joachim
Duyster, Justus
Finke, Jürgen
Gerbitz, Armin
Klusmann, Jan-Henning
Kobbe, Guido
Lübbert, Michael
Müller-Tidow, Carsten
Platzbecker, Uwe
Rösler, Wolf
Sauer, Martin Günther
Schmid, Christoph
Schroeder, Thomas
Stelljes, Mathias
Kröger, Nicolaus
Müller, Lutz P.
- DOI
-
10.1016/j.bbmt.2019.01.016
- URN
-
urn:nbn:de:bvb:384-opus4-775056
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:47 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zeiser, Robert
- Beelen, Dietrich W.
- Bethge, Wolfgang Andreas
- Bornhäuser, Martin
- Bug, Gesine
- Burchert, Andreas
- Christopeit, Maximilian Erich Joachim
- Duyster, Justus
- Finke, Jürgen
- Gerbitz, Armin
- Klusmann, Jan-Henning
- Kobbe, Guido
- Lübbert, Michael
- Müller-Tidow, Carsten
- Platzbecker, Uwe
- Rösler, Wolf
- Sauer, Martin Günther
- Schmid, Christoph
- Schroeder, Thomas
- Stelljes, Mathias
- Kröger, Nicolaus
- Müller, Lutz P.
- Universität Augsburg
- Elsevier
Time of origin
- 2019
Other Objects (12)
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
Epigenetic therapy of cancer : preclinical models and treatment approaches
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
Epigenetic therapy of cancer : preclinical models and treatment approaches
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Molekulare Mechanismen der normalen myeloischen Differenzierung und ihrer Störung bei akuten myeloischen Leukämien
MDS und akute myeloische Leukämie : ein biologisches und therapeutisches Kontinuum
Myelodysplastic syndromes and acute myeloid leukemia : a biological and therapeutic continuum
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia
Epigenetic therapy of cancer : preclinical models and treatment approaches
DNA-Methylierungssignaturen bei älteren Patienten mit akuter myeloischer Leukämie
Charakterisierung der antileukämischen Aktivität von drei Hydroxamat-Histondesacetylase-Inhibitoren
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia